Ovarian cancer is the eighth most common cancer in women worldwide,
affecting almost 314,000 women globally in 2020.
affecting almost 314,000 women globally in 2020.
There is currently no cure for ovarian cancer and doctors treat the
condition with a combination of chemotherapy, surgery, immunotherapy,
radiation therapy, and other targeted therapies.
Now researchers from Tel Aviv University in Israel have unveiled a new
potential treatment for ovarian cancer using RNA-based nanodrugs.
Researchers reported an 80% survival rate in animal models.
